Skip to main content

Table 4 The relationship of metabolic syndrome diagnosed by reversed National Cholesterol Education Program criteria with glycemic control among Type 2 Diabetes patients

From: Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with Type 2 Diabetes

Parameters

T2D without MetS (n = 70)

T2D with 3 etS factors (n = 136)

T2D with 4 MetS factors (n = 196)

T2D with 5 MetS factors (n = 82)

Fasting blood glucose (mmol/l)

7.8 (7.03–8.23)

8.0 (7.54–8.5)

8.0 (7.62–8.42)

8.8 (8.11–9.49)

P-value

0.395

0.356

0.021

Glycated hemoglobin (%)

7.6 (7.25–8.07)

7.5 (7.24–7.82)

7.7 (7.49–7.98)

8.4 (7.96–8.80)

P-value

0.624

0.747

0.018 (a0.001, b0.009)

C-peptide (pmol/l)

443 (385–509)

569 (515–628)

688 (633–747)

857 (752–975)

P-value

0.004

1.5 × 10−7 (c0.004)

4.1 × 10−11 (a1.4 × 10−6, b0.005)

Insulin resistance

2.3 (2.01–2.49)

2.6 (2.46–2.79)

2.9 (2.77–3.07)

3.5 (3.21–3.78)

P-value

0.01

3.1 × 10−6 (c0.01)

1.4 × 10−11 (a7.6 × 10−8, b0.0003)

  1. The result presented as geometric mean and 95% confidence interval of mean adjusted to age, sex, race, and history of diabetes
  2. T2D Type 2 Diabetes, MetS Metabolic syndrome
  3. aT2D patients with 5 MetS factors versus T2D patients with 3 MetS factors
  4. bT2D patients with 5 MetS factors versus T2D patients with 4 MetS factors
  5. cT2D patients with 4 MetS factors versus T2D patients with 3 MetS factors